Surgically Treated Left Ventricular Myxomas: A 75-Year Systematic Review of Patient Demographics, Tumour Characteristics, and Outcomes
Interdisciplinary CardioVascular and Thoracic Surgery · 2025
DOI: 10.1093/icvts/ivaf248 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, 2025. Verfasst von Hamza A Abdul-Hafez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Faculty of Medicine and Public Health, An-Najah National University, Nablus P4110257, Palestine. Hauptthemen laut MEDLINE: Heart Neoplasms, Myxoma, Cardiac Surgical Procedures, Heart Ventricles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
Cardiac myxomas are rare primary heart tumours, most commonly originating in the left atrium. A smaller proportion occurs in the left ventricle, where they are even more uncommon and present unique diagnostic and therapeutic challenges. This systematic review aims to characterize the clinical features, management strategies, and outcomes of left ventricular cardiac myxomas.
Methods
A systematic search of the PubMed database was conducted to identify articles published up to May 2025. A total of 174 cases of surgically treated left ventricular myxomas were included. Data were extracted on patient demographics, tumour characteristics, surgical approaches, and follow-up outcomes.
Results
Patients showed a broad geographic distribution, with the highest number of cases reported from the United States. The mean age was 38.2 ± 20.37 years, with a slight female predominance (48.9%). Tumours were most commonly attached to the left ventricular wall (43.7%) and inter-ventricular septum (25.3%). Complete surgical excision was achieved in 92.5% of cases and was strongly associated with survival; nearly all patients with complete resection survived, compared to only 20% among those without. Overall postoperative survival was high (83.9%), with a low mortality rate (2.9%). Survival rates were comparable across genders and age groups, although paediatric patients had a slightly higher mortality rate (9.1%).
Conclusions
This systematic review represents the most comprehensive analysis to date of surgically treated left ventricular myxomas. The findings highlight the importance of complete excision in achieving favourable outcomes and highlight demographic and geographic patterns that can inform clinical suspicion, surgical planning, and patient counselling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Faculty of Medicine and Public Health, An-Najah National University, Nablus P4110257, Palestine.
- Department of Cardiothoracic Surgery, Al-Makassed Charitable Society Hospital, Jerusalem, Palestine.
- Cardiac Surgery Department, Alrazi Hospital, Jenin, Palestine.
- Department of Cardiac Surgery, Palestine Medical Complex, Ramallah, Palestine.
Zitieren
APA
Abdul-Hafez, H. A., Sarama, A., Safadi, T., Khadra, M. N., Salman, H. H., Darwazah, A. K., & Alkhatib, H. (2025). Surgically Treated Left Ventricular Myxomas: A 75-Year Systematic Review of Patient Demographics, Tumour Characteristics, and Outcomes. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivaf248
Vancouver
Abdul-Hafez HA, Sarama A, Safadi T, Khadra MN, Salman HH, Darwazah AK, et al. Surgically Treated Left Ventricular Myxomas: A 75-Year Systematic Review of Patient Demographics, Tumour Characteristics, and Outcomes. Interdisciplinary CardioVascular and Thoracic Surgery. 2025. doi:10.1093/icvts/ivaf248
BibTeX
@article{AbdulHafez2025,
author = {Abdul-Hafez, Hamza A and Sarama, Asmaa and Safadi, Tammah and Khadra, Mahmoud N and Salman, Hasan Husni and Darwazah, Ahmad K and Alkhatib, Hasan},
title = {Surgically Treated Left Ventricular Myxomas: A 75-Year Systematic Review of Patient Demographics, Tumour Characteristics, and Outcomes},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2025},
doi = {10.1093/icvts/ivaf248}
}
EUVIMED